Companies: 10,795·Total market cap: $144.5T
Vera Therapeutics, Inc.

Vera Therapeutics, Inc.

VERANASDAQHealthcare● Active
$32.26
$-0.03(-0.09%)
Market Cap$2.3B
P/E Ratio
52W High$56.05
52W Low$19.066
Overview

Vera Therapeutics, Inc. (VERA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · VERA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-5.54vera eps ttm · vera earnings per shareEarnings history
PE Ratio (TTM)vera pe ratio ttm · vera price to earningsPE Ratio deep dive
Revenue (TTM)0.00vera revenue ttm · vera annual revenueFull revenue history
Dividend YieldNo Dividenddoes vera pay dividends · vera dividend yieldDividend history
Shares Outstanding64.2Mvera shares outstanding · vera floatShares outstanding history
Next EarningsAug 4, 2026Est.vera earnings date · vera next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
vera therapeutics, inc. revenue · vera revenue 2025
FY 2025Net Income-$299.6M▼ 96.92% YoY
202320242025
vera therapeutics, inc. net income · vera profit 2025
FY 2025EPS$-4.66▼ 69.45% YoY
202320242025
vera eps · vera therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$369.0MEPS: $-5.54View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy14 analystsis vera a buy · vera analyst rating
Strong Buy
1
Buy
12
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$33.00Low
$32.26Current
$68.50Avg Target112.34% upside
$91.00High
vera price target · vera 12 month forecast

Total: 14 · Buy rate: 92.9%

The VERA analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $68.50, representing +112.34% upside from the current price of $32.26.

Stock Performance

Full History
1D-0.09%
1W+3.20%
1M-10.86%
3M-17.43%
YTD-36.30%
1Y+45.38%
5Y+115.50%

About Vera Therapeutics, Inc.

CEOGary Barrera
IPO DateMay 14, 2021
Employees152
CountryUS
Websiteveratx.com

Vera Therapeutics, Inc. a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead pr…

what is vera therapeutics, inc. · vera stock overview · vera therapeutics, inc. company profile · who is vera therapeutics, inc. ceo · vera NASDAQ · vera therapeutics, inc. headquarters · vera therapeutics, inc. business segments

About Stock Overview & Key Data

Vera Therapeutics, Inc. (VERA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 14, 2021. As of the latest trading session, VERA stock price is $32.26, with a market capitalization of $2.3B. The stock has returned +45.38% over the past 12 months and -36.30% year-to-date.

According to 14 Wall Street analysts, the consensus rating for Vera Therapeutics, Inc. stock is Buy, with an average 12-month price target of $68.50. In fiscal year 2025, Vera Therapeutics, Inc. reported revenue of — and net income of -$299.6M. For detailed data — including Vera Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Vera Therapeutics, Inc. (VERA) stock price is $32.26. The stock is traded on NASDAQ under the ticker symbol VERA. The 52-week range is $19.07 – $56.05.

VERA stock priceVERA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice